Whether characterized as the CSR, business ethics or by another name, best practices in a given industry often fall short, thus causing efforts of businesses seeking to enhance their own CSR practices to fall short as well. A typical CSR version uses philanthropic donations to show the company's dedication to social welfare. Even a strategic variant of CSR falls short of what it could achieve. We seek to raise the bar higher, although these can be important efforts worth celebrating to be sure. Our case study focuses on the pharmaceutical industry due to our expertise working in and studying that business.
Dissatisfied with the range of present attempts, Section 3 switches from an inductive approach to a deductive one in which we rely on some monitory benchmarks and scholarly literature to propose a more powerful model of corporate ethics. At the heart of this model is the claim when they may be undertaken for true purposes rather than for instrumental ones that optimum instrumental gains accrue to corporate CSR activities. The Section 4 then illustrates how this framework delivers a method for pharmaceutical companies to embrace a more powerful model of corporate responsibility that may be extended to other industries too.
PUBLICATION DATE: March 15, 2014 PRODUCT #: BH590-HCB-ENG
The Paradox of Pharmaceutical CSR The Sincerity Nexus Case Study Solution
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Punch Up In the Potash Industry (A): Agrium Inc. – The Fertilizer Hits the Fan
Ramesh and Gargi (B)
Should Your Business Be Less Productive?
Suicides at France Telecom
Periodic Review Inventory Systems: Practice Problems
THE WATER CHALLENGE IN KENYA: A CHALLENGE OR AN OPPORTUNITY?
United Way
Tradition and Transformation at the Spanish Riding School of Vienna
Baggout: Growing a Social Curation Start-Up
SIN Capital and the Fullerton Health IPO
